Updated:
Solas BioVentures
Solas BioVentures is an SEC-registered investment adviser in Chattanooga, TN, registered since 2025. The firm manages approximately $165 million in assets.
Overview
Solas BioVentures is an SEC-registered investment adviser in Chattanooga, TN, registered since 2025. The firm manages approximately $165 million in assets. It has 6 employees and 5 investment advisers.
General information
Firm type
Venture Capital
Year founded
2015
Location
Region
North America
Country
United States
City
Chattanooga
Corporate office
Chattanooga, TN, United States
Principals
David Adair
Co-Founder & Managing Director
Mark Hackett
Co-Founder & Partner
David Belitz
Partner
Joshua Eckelberry
Partner
Travis Manasco
Partner
Michael Hoey
Co-founder (Advisory Team)
Sector focus
Frequently asked questions
Does Solas BioVentures invest only in the United States?
The firm's website states its reach is worldwide, and an International Relations role (held by Laurent Pacheco) confirms a global outlook. However, no specific non-US portfolio companies or offices are publicly disclosed.
Which sectors does Solas BioVentures explicitly avoid?
Solas BioVentures invests exclusively in the life science industry. The firm publishes no interest in enterprise software, consumer tech, fintech, or any sector outside biopharmaceuticals, medical devices, and digital health.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: